X-linked mental retardation: Vanishing boundaries between non-specific (MRX) and syndromic (MRXS) forms

Clinical Genetics

Volumn 62, Issue 6, 2002, Pages 423-432

  Frints, S G M ^a   Froyen, G ^a   Marynen, P ^a   Fryns, Jean Pierre ^b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Allelism; MRX; MRXS; X linked mental retardation

Indexed keywords

CELL SURFACE PROTEIN; FRAGILE X MENTAL RETARDATION PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; LONG CHAIN FATTY ACID COENZYME A LIGASE; PHOSPHOTRANSFERASE; PROTEIN KINASE; PROTEIN P21; RECEPTOR PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ALLELISM; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; FEMALE; FRAGILE X SYNDROME; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MALE; MENTAL DEFICIENCY; MENTAL RETARDATION MALFORMATION SYNDROME; PRIORITY JOURNAL; SEX DIFFERENCE; SHORT SURVEY; X CHROMOSOME LINKAGE; X CHROMOSOME LINKED DISORDER;

ANIMALS; FAMILY HEALTH; HUMANS; MENTAL RETARDATION, X-LINKED; MUTATION; SYNDROME;

EID: 0036948994     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2002.620601.x     Document Type: Short Survey

References (100)

1. Chelly J, Mandel JL. Monogenic causes of X-linked mental retardation. Nat Rev Genet 2001: 2: 669-680.
2. Stromme P, Valvatne K. Mental retardation in Norway: prevalence and sub-classification in a cohort of 30,037 children born between 1980 and 1985. Acta Paediatr 1998: 87: 291-296.
3. Roeleveld N, Zielhuis GA, Gabreels F. The prevalence of mental retardation: a critical review of recent literature. Dev Med Child Neurol 1997: 39: 125-132.
4. Van Buggenhout GJ, Trommelen JCM, Brunner HG, Hamel BCJ, Fryns JP. Clinical etiological survey of a population of 471 mentally retarded patients living in an institution in the Southern part of the Netherlands. Community Genet 2001: 4: 109-122.
5. Johnson GE. Contribution to the psychology and pedagogy of feebleminded children. J Psycho Asthenics 1897: 2: 26-32.
6. Godiland HH. Feeblemindedness. Its Causes and Consequences. New York: MacMillan, 1914.
7. Penrose LS. A Clinical and Genetic Study of 1280 Cases of Mental Defect. Medical Research Council Special Report Series 229. London: Medical Research Council, 1938.
8. Priest JH, Thulline HC, La Veck FG, Jarnis DB. An approach to genetic factors in mental retardation. Am J Ment Defic 1961: 66: 42-50.
9. Reed EW, Reed SC. Mental Retardation: A Family Study. Philadelphia: W. B. Saunders, 1965.
10. Martin JP, Bell J. A pedigree of mental defect showing sex-linkage. J Neurol Psychiat 1943: 6: 154-157.
11. Turner G, Turner B. X-linked mental retardation. J Med Genet 1974: 11: 109-113.
12. Lehrke R. Theory of X-linkage of major intellectual traits. Am J Ment Defic 1972: 76: 611-619.
13. Lehrke RG. X-linked mental retardation and verbal disability. Birth Defects Orig Artic Series 1974: 10: 1-100.
14. Sutherland GR. Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium. Science 1977: 197: 265-266.
15. Richards BW, Sylvester PE, Brooker C. Fragile X-linked mental retardation: the Martin-Bell syndrome. J Ment Defic Res 1981: 25 Part 4: 253-256.
16. Renpenning HJ, Gerrard JW, Zaleski WA, Tabuta T. Familial sex-linked mental retardation. Can Med Assoc J 1963: 87: 954-956.
17. Oostra BA, Chiurazzi P. The fragile X gene and its function. Clin Genet 2001: 60: 399-408.
18. Turner G, Webb T, Wake S, Robinson H. Prevalence of fragile X syndrome. Am J Medical Genet 1996: 64: 196-197.
19. Fryns JP. X-linked mental retardation and the fragile X syndrome: a clinical approach. In: Davies KE, ed. The Fragile X Syndrome. Oxford: Oxford University Press, 1989: 1-39.
20. Hamel BC, Chiurazzi P, Lubs HA. Syndromic XLMR genes (MRXS): update 2000. Am J Med Genet 2000: 94: 361-363.
21. Kerr B, Turner G, Mulley J, Gedeon A, Partington M. Non-specific X linked mental retardation. J Med Genet 1991: 28: 378-382.
22. Turner G. Intelligence and the X chromosome. Lancet 1996: 347: 1814-1815.
23. Turner G. Finding genes on the X chromosome by which homo may have become sapiens. Am J Hum Genet 1996: 58: 1109-1110.
24. Gecz J, Gedeon AK, Sutherland GR, Mulley JC. Identification of the gene FMR2, associated with FRAXE mental retardation. Nat Genet 1996: 13: 105-108.
25. Gu Y, Shen Y, Gibbs RA, Nelson DL. Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island. Nat Genet 1996: 13: 109-113.
26. D'Adamo P, Menegon A, Lo NC et al. Mutations in GDI1 are responsible for X-linked non-specific mental retardation [see comments] [published erratum appears in Nat Genet 1998 July; 19 (3): 303]. Nat Genet 1998: 19: 134-139.
27. Billuart P, Bienvenu T, Ronce N et al. Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature 1998: 392: 923-926.
28. Allen KM, Gleeson JG, Bagrodia S et al. PAK3 mutation in nonsyndromic X-linked mental retardation. Nat Genet 1998: 20: 25-30.
29. Merienne K, Jacquot S, Pannetier S et al. A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation [letter]. Nat Genet 1999: 22: 13-14.
30. Carrie A, Jun L, Bienvenu T et al. A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat Genet 1999: 23: 25-31.
31. Zemni R, Bienvenu T, Vinet MC et al. A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat Genet 2000: 24: 167-170.
32. Kutsche K, Yntema H, Brandt A et al. Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for rho GTPases, in patients with X-linked mental retardation. Nat Genet 2000: 26: 247-250.
33. Couvert P, Bienvenu T, Aquaviva C, et al. MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet 2001: 10: 941-946.
34. Meloni I, Muscettola M, Raynaud M et al. FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. Nat Genet 2002: 30: 436-440.
35. Stromme P, Mangelsdorf ME, Shaw MA et al. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat Genet 2002: 30: 441-445.
36. Bienvenu T, Poirier K, Friocourt G et al. ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation. Hum Mol Genet 2002: 11: 981-991.
37. Lubs H, Chiurazzi P, Arena J, Schwartz C, Tranebjaerg L, Neri G. XLMR genes: update 1998. Am J Med Genet 1999: 83: 237-247.
38. Gecz J, Mulley J. Genes for cognitive function: developments on the X. Genome Res 2000: 10: 157-163.
39. Chiurazzi P, Hamel BC, Neri G. XLMR genes: update 2000. Eur J Hum Genet 2001: 9: 71-81.
40. Mulley JC, Kerr B, Stevenson R, Lubs H. Nomenclature guidelines for X-linked mental retardation. Am J Med Genet 1992: 43: 383-391.
41. Knight SJ, Flannery AV, Hirst MC et al. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell 1993: 74: 127-134.
42. Hirst MC, Barnicoat A, Flynn G et al. The identification of a third fragile site, FRAXF, in Xq27-q28 distal to both FRAXA and FRAXE. Hum Mol Genet 1993: 2: 197-200.
43. Gecz J, Oostra BA, Hockey A et al. FMR2 expression in families with FRAXE mental retardation. Hum Mol Genet 1997: 6: 435-441.
44. Gecz J, Mulley JC. Characterisation and expression of a large, 13.7 kb FMR2 isoform. Eur J Hum Genet 1999: 7: 157-162.
45. Hillman MA, Gecz J. Fragile XE-associated familial mental retardation protein 2 (FMR2) acts as a potent transcription activator. J Hum Genet 2001: 46: 251-259.
46. Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev 2001: 81: 153-208.
47. Ramakers GJ. Rho proteins, mental retardation and the cellular basis of cognition. Trends Neurosci 2002: 25: 191-199.
48. Mackay DJ, Hall A. Rho GTPases. J Biol Chem 1998: 273: 20685-20688.
49. Dickson BJ. Rho GTPases in growth cone guidance. Curr Opin Neurobiol 2001: 11: 103-110.
50. Nikolic M. The role of Rho GTPases and associated kinases in regulating neurite outgrowth. Int J Biochem Cell Biol 2002: 34: 731-745.
51. Jaffer ZM, Chernoff J. p21-Activated kinases: three more join the Pak. Int J Biochem Cell Biol 2002: 34: 713-717.
52. Bienvenu T, des Portes V, McDonell N et al. Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation. Am J Med Genet 2000: 93: 294-298.
53. Feng Q, Albeck JG, Cerione RA, Yang W. Regulation of the Cool/Pix proteins: key binding partners of the Cdc42/ Rac targets, the p21-activated kinases. J Biol Chem 2002: 277: 5644-5650.
54. Berditchevski F, Odintsova E. Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signaling. J Cell Biol 1999: 146: 477-492.
55. Schoenwaelder SM, Burridge K. Bidirectional signaling between the cytoskeleton and integrins. Curr Opin Cell Biol 1999: 11: 274-286.
56. Stipp CS, Hemler ME. Transmembrane-4-superfamily proteins, CD151 and CD81, associate with alpha 3 beta 1 integrin, and selectively contribute to alpha 3 beta 1-dependent neurite outgrowth. J Cell Sci 2000: 113: 1871-1882.
57. Zhang XA, Bontrager AL, Hemler ME. Transmembrane-4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific beta(1) integrins. J Biol Chem 2001: 276: 25005-25013.
58. Yauch RL, Hemler ME. Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphoinositide 4-kinase. Biochem J 2000: 351 Part 3: 629-637.
59. Rohrbough J, Grotewiel MS, Davis RL, Broadie K. Integrin-mediated regulation of synaptic morphology, transmission, and plasticity. J Neurosci 2000: 20: 6868-6878.
60. Born TL, Smith DE, Garka KE, Renshaw BR, Bertles JS, Sims JE. Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signaling. J Biol Chem 2000: 275: 29946-29954.
61. Faergeman NJ, Knudsen J. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. Biochem J 1997: 323: 1-12.
62. Rapoport SI. In vivo fatty acid incorporation into brain phosholipids in relation to plasma availability, signal transduction and membrane remodeling. J Mol Neurosci 2001: 16: 243-261.
63. Martin RE, Bazan NG. Changing fatty acid content of growth cone lipids prior to synaptogenesis. J Neurochem 1992: 59: 318-325.
64. Rapoport SI, Chang MC, Spector AA. Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J Lipid Res 2001: 42: 678-685.
65. Stevenson RE. Splitting and lumping in the nosology of XLMR. Am J Med Genet 2000: 97: 174-182.
66. Delaunoy J, Abidi F, Zeniou M et al. Mutations in the X-linked RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome. Hum Mutat 2001: 17: 103-116.
67. Dotti MT, Orrico A, De Stefano N et al. A Rett syndrome MECP2 mutation that causes mental retardation in men. Neurology 2002: 58: 226-230.
68. Zeniou M, Pannetier S, Fryns JP, Hanauer A. Unusual splice-site mutations in the RSK2 gene and suggestion of genetic heterogeneity in Coffin-Lowry syndrome. Am J Hum Genet 2002: 70: 1421-1433.
69. Harum KH, Alemi L, Johnston MV. Cognitive impairment in Coffin-Lowry syndrome correlates with reduced RSK2 activation. Neurology 2001: 56: 207-214.
70. Frodin M, Jensen CJ, Merienne K, Gammeltoft S. A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1. EMBO J 2000: 19: 2924-2934.
71. Percy AK. Rett syndrome: clinical correlates of the newly discovered gene. Brain Dev 2001: 23 (Suppl. 1): S202-S205.
72. Bienvenu T, Carrie A, de Roux N et al. MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet 2000: 9: 1377-1384.
73. Topcu M, Akyerli C, Sayi A et al. Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy. Eur J Hum Genet 2002: 10: 77-81.
74. Zeev BB, Yaron Y, Schanen NC et al. Rett syndrome: clinical manifestations in males with MECP2 mutations. J Child Neurol 2002: 17: 20-24.
75. Meloni I, Bruttini M, Longo I et al. A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet 2000: 67: 982-985.
76. Klauck SM, Lindsay S, Beyer KS, Splitt M, Burn J, Poustka A. A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. Am J Hum Genet 2002: 70: 1034-1037.
77. Yntema HG, Oudakker AR, Kleefstra T et al. In-frame deletion in MECP2 causes mild nonspecific mental retardation. Am J Med Genet 2002: 107: 81-83.
78. Yntema HG, Kleefstra T, Oudakker AR et al. Low frequency of MECP2 mutations in mentally retarded males. Eur J Hum Genet 2002: 10: 487-490.
79. Tucker KL. Methylated cytosine and the brain: a new base for neuroscience. Neuron 2001: 30: 649-652.
80. Guy J, Hendrich B, Holmes M, Martin JE, Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 2001: 27: 322-326.
81. Chen RZ, Akbarian S, Tudor M, Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 2001: 27: 327-331.
82. Robertson KD, Wolffe AP. DNA methylation in health and disease. Nat Rev Genet 2000: 1: 11-19.
83. Yntema H, Poppelaars FA, Derksen E et al. Expanding phenotype of XNP mutations: mild to moderate mental retardation. Am J Med Genet 2002: 110: 243-247.
84. Lebel R, May M, Pouls S, Lubs H, Stevenson R, Schwartz C. Non-syndromic X-linked mental retardation associated with a missense mutation (P312L) in the FGD1 gene. Clin Genet 2002: 61: 139-145.
85. Salomons GS, van Dooren SJ, Verhoeven NM et al. X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am J Hum Genet 2001: 68: 1497-1500.
86. Hahn KA, Salomons GS, Tackels-Horne D et al. X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28. Am J Hum Genet 2002: 70: 1349-1356.
87. Vervoort VS, Beachem MA, Edwards PS et al. AGTR2 mutations in X-linked mental retardation. Science 2002: 296: 2401-2403.
88. Gecz J, Barnett S, Liu J et al. Characterization of the human glutamate receptor subunit 3 gene (GRIA3), a candidate for bipolar disorder and nonspecific X-linked mental retardation. Genomics 1999: 62: 356-368.
89. Scheer MPMS, Kubart S, Schulz A et al. DXS6673E encodes a predominantly nuclear protein, and its mouse ortholog DXHXS6673E is alternatively spliced in a developmental- and tissue-specific manner. Genomics 2000: 63: 123-132.
90. Yntema HGHB, Kissing J, van Duijnhoven G et al. A novel ribosomal S6-kinase (RSK4; RPS6KA6) is commonly deleted in patients with complex X-linked mental retardation. Genomics 1999: 62: 332-343.
91. Fukami M, Kirsch S, Schiller S et al. A member of a gene family on Xp22.3, VCX-A, is deleted in patients with X-linked nonspecific mental retardation. Am J Hum Genet 2000: 67: 563-573.
92. Curry CJ, Stevenson RE, Aughton D et al. Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet 1997: 72: 468-477.
93. Fisch GS. Psychological assessment in XLMR: a proposal for setting international standards. Genet Couns 2000: 11: 85-101.
94. Tsutada T, Ikeda H, Tsuyuguchi N et al. Detecting functional asymmetries through the dipole moment of magnetoencephalography. J Neurol Sci 2002: 198: 51-61.
95. Strange BA, Fletcher PC, Henson RN, Friston KJ, Dolan RJ. Segregating the functions of human hippocampus. Proc Natl Acad Sci USA 1999: 96: 4034-4039.
96. Cai WW, Mao JH, Chow CW, Damani S, Balmain A, Bradley A. Genome-wide detection of chromosomal imbalances in tumors using BAC microarrays. Nat Biotechnol 2002: 20: 393-396.
97. Lockhart DJ, Barlow C. Expressing what's on your mind: DNA arrays and the brain. Nat Rev Neurosci 2001: 2: 63-68.
98. Gu Y, McIlwain KL, Weeber EJ et al. Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knockout mice. J Neurosci 2002: 22: 2753-2763.
99. D'Adamo P, Welzl H, Papadimitriou S et al. Deletion of the mental retardation gene Gdi1 impairs associative memory and alters social behavior in mice. Hum Mol Genet 2002: 11: 2567-2580.
100. Morales J, Hiesinger PR, Schroeder AJ et al. Drosophila fragile X protein, DFXR, regulates neuronal morphology and function in the brain. Neuron 2002: 34: 961-972.